Draupnir Bio
Latest round
- Seed
Last raised
- Jul 2024
Total raised
- $47M
Investors
- 6
About Draupnir Bio
Established in 2017 and based in Frederiksberg, Denmark, Draupnir Bio ApS is a biotechnology company that develops small molecule modulators of PCSK9 (proprotein convertase subtilisin Kexin type 9) providing treatment for heart disease. The company was founded by Simon Glerup, Camilla Gustafsen, Peder Madsen, and Peter Seeberger as a spin-out from Aarhus University in Denmark and the Max-Planck Society in Germany. The company develops small molecule modulators of PCSK9 (proprotein convertase subtilisin kexin type 9) for the treatment of heart disease and ailments. It regulates the recycling of the hepatic LDL receptor to modulate the interaction of PCSK9 with the LDL receptor to lower the blood LDL cholesterol and the risk of heart disease. The company's revenue is generated by the sales of its small molecule modulator solutions for personal and industrial use.
Who invested in Draupnir Bio
6 investors across 2 rounds
See all investors in Draupnir Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Draupnir Bio
Who invested in Draupnir Bio?
Draupnir Bio has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Draupnir Bio raised?
Draupnir Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Draupnir Bio last raise money?
Draupnir Bio's most recent round on record is a Seed, in Jul 2024.
What does Draupnir Bio do?
Established in 2017 and based in Frederiksberg, Denmark, Draupnir Bio ApS is a biotechnology company that develops small molecule modulators of PCSK9 (proprotein convertase subtilisin Kexin type 9) providing treatment for heart disease.
Where is Draupnir Bio headquartered?
Draupnir Bio is headquartered in Frederiksberg, Denmark.
Which VCs invest in companies like Draupnir Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Draupnir Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Draupnir Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.